glp 1 atrial fibrillation Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit Frontiers | The potential of

This is a documented personal account not a prescription or recommendation

doi: 10.1097/00003246-200104000-00005 49 SefikEQuRJunqueiraCKaffeEMirzaHZhaoJet al

Sid, B., Verrax, J

Cytoplasmic translocation, aggregation, and cleavage of TDP-43 by enteroviral proteases modulate viral pathogenesis

Arginine is available as a pharmaceutical supplement and is used to address various conditions

Allulose follows a completely different pharmacokinetic route (excreted intact through urine and not dealing with platelets at all), so there is no scientific basis for those cardiovascular concerns about sugar alcohols to be put on D-allulose